TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Redsense Medical AB (publ)
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
2,453
|
2,250
|
1,289 |
| Financial expenses |
3
|
142
|
9 |
| Earnings before taxes |
30
|
-407
|
-787 |
| EBITDA |
24
|
-448
|
-913 |
| Total assets |
3,639
|
2,389
|
2,762 |
| Current assets |
2,437
|
1,194
|
1,619 |
| Current liabilities |
193
|
307
|
322 |
| Equity capital |
3,446
|
2,081
|
2,440 |
| - share capital |
143
|
127
|
126 |
| Employees (average) |
5
|
5
|
5 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
94.7%
|
87.1%
|
88.3% |
| Turnover per employee |
491
|
450
|
258 |
| Profit as a percentage of turnover |
1.2%
|
-18.1%
|
-61.1% |
| Return on assets (ROA) |
0.9%
|
-11.1%
|
-28.2% |
| Current ratio |
1262.7%
|
388.9%
|
502.8% |
| Return on equity (ROE) |
0.9%
|
-19.6%
|
-32.3% |
| Change turnover |
279
|
958
|
447 |
| Change turnover % |
13%
|
74%
|
53% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.